Audientes
Market Cap
kr.66.4m
Last Updated
2021/01/26 18:01 UTC
Data Sources
Company Financials
Executive Summary
Audientes A/S design, develops, and sells hearing aids. More Details
Risk Analysis
Snowflake Analysis
Weak fundamentals or lack of information.
Share Price & News
How has Audientes's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: AUDNTS is more volatile than 75% of Danish stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: Insufficient data to determine AUDNTS's volatility change over the past year.
Market Performance
7 Day Return
-2.9%
AUDNTS
4.1%
DK Medical Equipment
1.3%
DK Market
1 Year Return
n/a
AUDNTS
23.0%
DK Medical Equipment
26.9%
DK Market
Return vs Industry: Insufficient data to determine how AUDNTS performed against the Danish Medical Equipment industry.
Return vs Market: Insufficient data to determine how AUDNTS performed against the Danish Market.
Shareholder returns
| AUDNTS | Industry | Market | |
|---|---|---|---|
| 7 Day | -2.9% | 4.1% | 1.3% |
| 30 Day | 19.3% | 1.5% | 3.2% |
| 90 Day | 2.9% | 4.8% | 13.1% |
| 1 Year | n/a | 24.4%23.0% | 29.3%26.9% |
| 3 Year | n/a | 81.8%75.3% | 56.1%43.9% |
| 5 Year | n/a | 135.9%116.9% | 68.0%46.4% |
Long-Term Price Volatility Vs. Market
How volatile is Audientes's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Valuation
Is Audientes undervalued compared to its fair value and its price relative to the market?
In this section, we usually try to help investors determine whether Audientes is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Audientes has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.
This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.
Next Steps
- Take a look at our analysis of AUDNTS's management and see if the CEO's compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
- When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don't know where to start, we recommend reading through Audientes regulatory filings.
- Explore potentially undervalued companies in the Healthcare industry.
Future Growth
How is Audientes forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
18.9%
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Audientes has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Next Steps
- Take a look at our analysis of AUDNTS’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
- Audientes competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Healthcare industry.
Past Performance
How has Audientes performed over the past 5 years?
8.0%
Historical Healthcare annual earnings growth
In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Audientes has not provided sufficient past data to assess its track record.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.
Next Steps
- When a company lacks a financial track record, its management’s track record becomes important. Corporate governance also plays an important role in a young business as board members are seen as highly-experienced leaders to help steer the company into the future. Take a look at Audientes's management and board experience and expertise to assess their ability to deliver on their strategic promises.
- Explore strong past performing companies in the Healthcare industry.
Financial Health
How is Audientes's financial position?
In this section we usually analyse Audientes's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Audientes has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.
Next Steps
- Take a look at our analysis of AUDNTS’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
- Investors tend to look at the financial health of a company this size in order to assess the sustainability of its current operations. Audientes's cash and debt levels may be found in its annual reports archived here.
- Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when Audientes's financial data was last updated here.
- Explore more healthy companies in the Healthcare industry.
Dividend
What is Audientes's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate AUDNTS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate AUDNTS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if AUDNTS's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if AUDNTS's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of AUDNTS's dividend in 3 years as they are not forecast to pay a notable one for the Danish market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
1.0yrs
Average management tenure
CEO
Steen Thygesen
no data
Tenure
Mr. Steen Thygesen serves as Chief Executive Officer and Member of Executive Board at Audientes A/S. He has a bachelor degree in Electronics Engineering from Copenhagen’s Engineering College, and an MBA fr...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Member of Executive Board | no data | no data | no data | |
| Founder | 7yrs | no data | no data | |
| Head of Operations | 1yr | no data | no data | |
| Chief Marketing Officer | 1yr | no data | no data | |
| Head of Wholesale | 1yr | no data | no data | |
| Head of E-Commerce | 1yr | no data | no data | |
| Head of UX | 1yr | no data | no data | |
| Country Head of India | no data | no data | no data |
1.0yrs
Average Tenure
Experienced Management: AUDNTS's management team is not considered experienced ( 1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board | 0.58yr | no data | no data | |
| Board Member | 0.58yr | no data | no data | |
| Board Member | 0.58yr | no data | no data |
0.6yrs
Average Tenure
Experienced Board: AUDNTS's board of directors are not considered experienced ( 0.6 years average tenure), which suggests a new board.
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: AUDNTS only recently listed within the past 12 months.
Top Shareholders
Company Information
Audientes A/S's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Audientes A/S
- Ticker: AUDNTS
- Exchange: CPSE
- Founded: 2014
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: kr.66.378m
- Shares outstanding: 9.35m
- Website: https://www.audientes.com
Location
- Audientes A/S
- Teknikerbyen 5
- Virum
- Capital Region of Denmark
- 2830
- Denmark
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| AUG | DB (Deutsche Boerse AG) | Yes | Share Capital | DE | EUR | Sep 2020 |
| AUDNTS | CPSE (OMX Nordic Exchange Copenhagen) | Yes | Share Capital | DK | DKK | Sep 2020 |
Biography
Audientes A/S design, develops, and sells hearing aids. The company was founded in 2014 and is based in Virum, Denmark.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/01/26 18:01 |
| End of Day Share Price | 2021/01/26 00:00 |
| Earnings | N/A |
| Annual Earnings | N/A |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.